Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes

Transplantation

Volumn 63, Issue 11, 1997, Pages 1691-1694

  Emanuel, David J ^a,b   Lucas, Kenneth G ^a,b   Mallory Jr , George B ^c   Edwards Brown, Mary K ^a   Pollok, Karen E ^b   Conrad, Patricia D ^a,b   Robertson, Kent A ^a,b   Smith, Franklin O ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN;

ADOPTIVE TRANSFER; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CASE REPORT; CENTRAL NERVOUS SYSTEM; CYSTIC FIBROSIS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GRAFT REJECTION; HLA SYSTEM; HUMAN; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MONONUCLEAR CELL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL TRANSPLANTATION;

ANTILYMPHOCYTE SERUM; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; GRAFT REJECTION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY, ADOPTIVE; LEUKOCYTE TRANSFUSION; LUNG TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030916763     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199706150-00027     Document Type: Article

References (20)

1. Straus SE, Cohen JI, Tosato G, Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis and management. Ann Intern Med 1993; 118: 45.
2. Leblond V, Sutton L, Dorent R, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 1995; 13(4): 961.
3. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphological and molecular genetic analysis demonstrates three distinctive categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85(2): 552.
4. Starzl TE, Porter KA, Iwatsuki S. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984; 1: 583.
5. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Balfour HH Jr, Simmons RL, Najarian JS. Acyclovir therapy of Epstein-Barr virus-induced post-transplant lymphoproliferative diseases. Transplant Proc 1985; 17: 89.
6. Shapiro RS, Chauvenet A, McGuire W, et al. Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N Engl J Med 1988; 318: 1334.
7. Papadopoulos E, Ladanyi M, Emanuel DJ, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330: 1185.
8. Rooney C, Smith C, Ng C, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 1995; 345: 9.
9. Spiro IJ, Yandell DW, Li C, et al. Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. N Engl J Med 1993; 329: 27.
10. Yousern SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant 1996; 15(1): 1.
11. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients Cancer Res 1981; 41: 4262.
12. Cheung A, Kieff E. Long internal repeat in Epstein-Barr virus DNA. J Virol 1982; 44: 286.
13. Akao I, Sato Y, Mukai K, et al. Detection of Epstein-Barr virus DNA in formalin fixed paraffin embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in-situ hybridization. Laryngoscope 1991; 101: 279.
14. Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ. The development of cellular immunity to Epstein-Barr virus following allogeneic bone marrow transplantation. Blood 1996; 87(6): 2594.
15. Allen R, Budowle B, Charkraborty R, Giusti A, Eisenberg A. Analysis of the VNTR locus AmpliFLP D1S80 by PCR followed by high resolution PAGE. Am J Hum Genet 1991; 48: 137.
16. Kolb HJ, Mittermuller J, Clemm CH, et al. Donor leukocyte transfusions for the treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462.
17. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333(16): 1038.
18. Scott JP, Sharples L, Mullins P, et al. Further studies on the natural history of obliterative bronchiolitis following heart-lung transplantation. Transplant Proc 1991; 23(1): 1201.
19. Whitehead B, Rees P, Sorenson K, et al. Incidence of obliterative bronchiolitis after heart-lung transplantation in children. J Heart Lung Transplant 1993; 12(6): 903.
20. Scott JP, Higenbottam TW, Sharples L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51: 813.